Overview

A Study To Assess the Immune Response Following Administration Of Influenza and Pneumococcal Vaccines To Subjects With Rheumatoid Arthritis Receiving CP-690,550 Or Placebo

Status:
Completed

Trial end date:
2012-02-01

Target enrollment:

Participant gender:

Summary

A Randomized, Double Blind, Placebo Controlled Phase 2 Study To assess the Immune Response Following Administration of Influenza and Pneumococcal Vaccines to Subjects with Rheumatoid Arthritis receiving CP-690,550 with and Without background Methotrexate

Phase:

Phase 2

Details

Lead Sponsor:

Pfizer

Treatments:

Heptavalent Pneumococcal Conjugate Vaccine
Methotrexate
Tofacitinib
Vaccines